What We're Reading: Page 74
Industry reads hand-picked by our editors
Nov 15, 2023
-
Reuters
Drugmaker Mallinckrodt emerges from bankruptcy
-
The Boston Globe
EMD Serono plans to join biopharma cluster in Boston’s Seaport
-
KFF Health News
Biden Administration’s Limit on Drug Industry Middlemen Backfires, Pharmacists Say
-
NPR
Roland Pattillo protected Henrietta Lacks’ memory. He died leaving that legacy
Nov 14, 2023
-
Health Affairs
What’s The Worst That Could Happen? A Toothless FDA
-
Fierce Biotech
Hepatitis B drug developers chart slow progress, just like in hep C
-
Regulatory Focus
FDA announces OPQ reorganization to alleviate ‘long-standing pain points’
-
The Transmitter
Making cancer nervous
Nov 13, 2023
Nov 10, 2023
-
Investor’s Business Daily
Amylyx Stock Crashes As Patients Drop Off ALS Drug, Relyvrio
-
Axios
“I’ve never seen anything like this”: High demand fuels drug shortages
-
MIT Technology Review
How open-source drug discovery could help us in the next pandemic
Nov 09, 2023
Nov 08, 2023
-
The Washington Post
Bertagnolli confirmed as new head of National Institutes of Health
-
Bloomberg
Elon Musk’s Neuralink Brain Implant Startup Is Ready to Start Surgery
-
The Wall Street Journal
Same Drug, Two Prices: Why The Higher Price Prevails
Previous
